Direvo, a company focusing on the biomass conversion industry, develops and implements biology-based solutions to improve economics of renewable fuels and livestock feeding markets. Customers include large and small industrial companies. Direvo has recently demonstrated a strong proof-of-concept for its enzyme engineering activities in creating a temperature-stable, pH-stable mannanase for animal feed and technical applications. Direvo’s sister company, Direvo Biotech, was acquired by Bayer HealthCare in 2008 for $300 million.

The Company is based in Cologne, Germany.